Heikkinen AM - Search Results

1

Does vitamin D strengthen the increase in femoral neck BMD in osteoporotic women treated with estrogen?

Tuppurainen MT, Komulainen M, Kröger H, Honkanen R, Jurvelin J, Puntila E, Heikkinen AM, Alhava E, Saarikoski S. Tuppurainen MT, et al. Among authors: heikkinen am. Osteoporos Int. 1998;8(1):32-8. doi: 10.1007/s001980050045. Osteoporos Int. 1998. PMID: 9692075 Clinical Trial.

2

Relation of estrogen receptor-alpha gene polymorphism and hormone replacement therapy to fall risk and muscle strength in early postmenopausal women.

Salmén T, Heikkinen AM, Mahonen A, Kröger H, Komulainen M, Saarikoski S, Honkanen R, Partanen J, Mäenpää PH. Salmén T, et al. Among authors: heikkinen am. Ann Med. 2002;34(1):64-72. doi: 10.1080/078538902317338661. Ann Med. 2002. PMID: 12014437 Free article. Clinical Trial.

3

Relation of androgen receptor gene polymorphism to bone mineral density and fracture risk in early postmenopausal women during a 5-year randomized hormone replacement therapy trial.

Salmén T, Heikkinen AM, Mahonen A, Kröger H, Komulainen M, Pallonen H, Saarikoski S, Honkanen R, Mäenpää PH. Salmén T, et al. Among authors: heikkinen am. J Bone Miner Res. 2003 Feb;18(2):319-24. doi: 10.1359/jbmr.2003.18.2.319. J Bone Miner Res. 2003. PMID: 12568409 Free article. Clinical Trial.

4

Leucine7 to proline7 polymorphism in prepro-NPY gene and femoral neck bone mineral density in postmenopausal women.

Heikkinen AM, Niskanen LK, Salmi JA, Koulu M, Pesonen U, Uusitupa MI, Komulainen MH, Tuppurainen MT, Kröger H, Jurvelin J, Saarikoski S. Heikkinen AM, et al. Bone. 2004 Sep;35(3):589-94. doi: 10.1016/j.bone.2004.05.004. Bone. 2004. PMID: 15336593 Clinical Trial.

5

Effects of postmenopausal hormone replacement therapy with and without vitamin D3 on circulating levels of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D.

Heikkinen A, Parviainen MT, Tuppurainen MT, Niskanen L, Komulainen MH, Saarikoski S. Heikkinen A, et al. Calcif Tissue Int. 1998 Jan;62(1):26-30. doi: 10.1007/s002239900389. Calcif Tissue Int. 1998. PMID: 9405729 Clinical Trial.

6

Does vitamin D3 have negative effects on serum levels of lipids? A follow-up study with a sequential combination of estradiol valerate and cyproterone acetate and/or vitamin D3.

Tuppurainen M, Heikkinen AM, Penttilä I, Saarikoski S. Tuppurainen M, et al. Among authors: heikkinen am. Maturitas. 1995 Jun;22(1):55-61. doi: 10.1016/0378-5122(95)00909-5. Maturitas. 1995. PMID: 7666817 Clinical Trial.

7

Vitamin D and HRT: no benefit additional to that of HRT alone in prevention of bone loss in early postmenopausal women. A 2.5-year randomized placebo-controlled study.

Komulainen M, Tuppurainen MT, Kröger H, Heikkinen AM, Puntila E, Alhava E, Honkanen R, Saarikoski S. Komulainen M, et al. Among authors: heikkinen am. Osteoporos Int. 1997;7(2):126-32. doi: 10.1007/BF01623687. Osteoporos Int. 1997. PMID: 9166392 Clinical Trial.

8

Biochemical bone markers and bone mineral density during postmenopausal hormone replacement therapy with and without vitamin D3: a prospective, controlled, randomized study.

Heikkinen AM, Parviainen M, Niskanen L, Komulainen M, Tuppurainen MT, Kröger H, Saarikoski S. Heikkinen AM, et al. J Clin Endocrinol Metab. 1997 Aug;82(8):2476-82. doi: 10.1210/jcem.82.8.4177. J Clin Endocrinol Metab. 1997. PMID: 9253321 Clinical Trial.

9

Long-term vitamin D3 supplementation may have adverse effects on serum lipids during postmenopausal hormone replacement therapy.

Heikkinen AM, Tuppurainen MT, Niskanen L, Komulainen M, Penttilä I, Saarikoski S. Heikkinen AM, et al. Eur J Endocrinol. 1997 Nov;137(5):495-502. doi: 10.1530/eje.0.1370495. Eur J Endocrinol. 1997. PMID: 9405029 Clinical Trial.

10

Prevention of femoral and lumbar bone loss with hormone replacement therapy and vitamin D3 in early postmenopausal women: a population-based 5-year randomized trial.

Komulainen M, Kröger H, Tuppurainen MT, Heikkinen AM, Alhava E, Honkanen R, Jurvelin J, Saarikoski S. Komulainen M, et al. Among authors: heikkinen am. J Clin Endocrinol Metab. 1999 Feb;84(2):546-52. doi: 10.1210/jcem.84.2.5496. J Clin Endocrinol Metab. 1999. PMID: 10022414 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

96 results

Search Page

Filters